Lens On The Scientific Market
Key findings from our industry experts.
Key findings from our industry experts.
NAMs Shift from Policy to Practice: What Life Science R&D Suppliers Need to Know in 2026
March 11, 2026 3:51 pm
BioInformatics, part of the Science and Medicine Group, is the leading research and advisory firm serving the life science and diagnostic industries. Our expertise includes primary quantitative and qualitative research in addition to secondary research and published reports. We own a proprietary, international community of more than 55,000 scientists and biomedical researchers to provide insights that grow businesses and move markets. Our multi-disciplinary team is comprised of industry veterans, market research experts, and survey statisticians.

Mobile Marketing to Life Scientists (Part 1): A Mobile Reach
Our August 2012 market report, “Mobile Marketing to Life Scientists” reveals that up to 25% of life scientists are very interested in interacting with their lab suppliers through mobile marketing programs similar to the ones they benefit from in their personal lives.
The Market for Primary Cells (Part 4): Choosing Between Primary Cells and Pluripotent Stem Cells
About 30% of the respondents indicated that they planned to evaluate the use of stem cell-derived cells within the next 12-months.
The Primary Cells Market (Part 3): Bundled Shopping
The demand for hepatocytes is met by many of the major commercial suppliers [e.g., Lonza, Gibco (Life Technologies)] as well as entities with a near exclusive focus on the needs of ADME/Toxicology researchers [e.g., Xenotech, Celsis IVT, BD Gentest (Corning Life Sciences)].
The Primary Cells Market (Part 2): Most Likely to Use Primary Cells
We also found that peripheral blood mononuclear cells (PMBCs), fibroblasts from various tissues and neurons are the most frequently used types of primary cells, and that there is very little difference between academic and industrial respondents in terms of cell types used with the exception of primary hepatocytes. 23% of the industrial respondents cite the use of hepatocytes, making them the second most widely used cell type in this segment.
The Primary Cells Market (Part 1): Sources of Primary Cells for Research
Primary cell cultures more closely mimic the physiological state of cells in vivo and generate more relevant data representing living systems compared to transformed continuous cell lines. Primary cells are widely used—over half of those who perform cell culture use primary cells to achieve their research objectives.
Customer Experience Touchpoints
Smart companies continually evaluate customer reactions to multiple touchpoints so that they can offer the kind of experience that inspires customers to want to come back.
The Value of Trending Studies in your Scientific Product’s Lifecycle
In life science tools markets, manufacturers are relying on their brand perception and improved customer experiences to differentiate.
Biosimilars: Emerging Opportunities for Lab Suppliers
Analytical instrumentation suppliers should be considering the imminent development of the biosimilars market for biotherapeutics.
Scientists Sound off on the Sequester
While it may be fewer guns and butter for everyone, life sciences will be hit particularly hard.
Biosimilars: How the FDA is Boosting Demand in the Analytical Instrumentation Market
Establishing a regulatory pathway for pharmaceutical companies in the U.S. to manufacture biosimilar drugs presents a much anticipated new market opportunity for life science analytical instrument suppliers.